The AETHERA trial: Results of a randomized, double-blind, placebo-controlled phase 3 study of brentuximab vedotin in the treatment of patients at risk of progression following autologous stem cell transplant for Hodgkin lymphoma Meeting Abstract
| Authors: | Moskowitz, C. H.; Nadamanee, A.; Masszi, T.; Agura, E.; Holowiecki, J.; Abidi, M. H.; Chen, A.; Stiff, P. J.; Gianni, A. M.; Carella, A. M.; Osmanov, D.; Bachanova, V.; Sweetenham, J.; Sureda, A.; Huebner, D.; Larsen, E. K.; Hunder, N. N. H.; Walewski, J. |
| Abstract Title: | The AETHERA trial: Results of a randomized, double-blind, placebo-controlled phase 3 study of brentuximab vedotin in the treatment of patients at risk of progression following autologous stem cell transplant for Hodgkin lymphoma |
| Meeting Title: | 2015 BMT Tandem Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 21 |
| Issue: | 2 Suppl. 1 |
| Meeting Dates: | 2015 Feb 11-15 |
| Meeting Location: | San Diego, CA |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-02-01 |
| Start Page: | S28 |
| Language: | English |
| ACCESSION: | WOS:000348633000009 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2014.11.017 |
| Notes: | CIBMTR Best Abstract Awards for Clinical Research; Meeting Abstract: 4 -- BMT Tandem Meetings -- FEB 11-15, 2015 -- San Diego, CA -- 1 -- Source: Wos |
